In light of the pathogenic role of HMGB1 in lethal sepsis, we explored the therapeutic potential of targeting the PKM2–EIF2AK2 pathway with drugs in animal models of lethal endotoxemia and polymicrobial sepsis induced by caecal ligation and puncture (CLP). This evidence concerns the gene EIF2AK2 and serum lipopolysaccharide activity.